Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Cancer Centre Amsterdam, Amsterdam, the Netherlands.
Br J Surg. 2023 Sep 6;110(10):1300-1308. doi: 10.1093/bjs/znad160.
RCTs are essential in guiding clinical decision-making but are difficult to perform, especially in surgery. This review assessed the trend in volume and methodological quality of published surgical RCTs over two decades.
PubMed was searched systematically for surgical RCTs published in 1999, 2009, and 2019. The primary outcomes were volume of trials and RCTs with a low risk of bias. Secondary outcomes were clinical, geographical, and funding characteristics.
Some 1188 surgical RCTs were identified, of which 300 were published in 1999, 450 in 2009, and 438 in 2019. The most common subspecialty in 2019 was gastrointestinal surgery (50.7 per cent). The volume of surgical RCTs increased mostly in Asia (61, 159, and 199 trials), especially in China (7, 40, and 81). In 2019, countries with the highest relative volume of published surgical RCTs were Finland and the Netherlands. Between 2009 and 2019, the proportion of RCTs with a low risk of bias increased from 14.7 to 22.1 per cent (P = 0.004). In 2019, the proportion of trials with a low risk of bias was highest in Europe (30.5 per cent), with the UK and the Netherlands as leaders in this respect.
The volume of published surgical RCTs worldwide remained stable in the past decade but their methodological quality improved. Considerable geographical shifts were observed, with Asia and especially China leading in terms of volume. Individual European countries are leading in their relative volume and methodological quality of surgical RCTs.
随机对照试验对于指导临床决策至关重要,但实施起来却很困难,尤其是在外科领域。本研究评估了过去 20 年来发表的外科随机对照试验的数量和方法学质量趋势。
系统检索 1999 年、2009 年和 2019 年发表的外科随机对照试验文献。主要结局是试验数量和低偏倚风险的随机对照试验数量。次要结局是临床、地理和资金特征。
共纳入 1188 项外科随机对照试验,其中 300 项发表于 1999 年,450 项发表于 2009 年,438 项发表于 2019 年。2019 年最常见的亚专科是胃肠外科(50.7%)。亚洲的外科随机对照试验数量增长最多(61、159 和 199 项),尤其是中国(7、40 和 81 项)。2019 年,发表外科随机对照试验相对数量最多的国家是芬兰和荷兰。2009 年至 2019 年间,低偏倚风险的随机对照试验比例从 14.7%增加到 22.1%(P=0.004)。2019 年,欧洲低偏倚风险试验的比例最高(30.5%),英国和荷兰在此方面处于领先地位。
过去 10 年,全球发表的外科随机对照试验数量保持稳定,但方法学质量有所提高。观察到显著的地理转移,亚洲特别是中国在数量方面处于领先地位。个别欧洲国家在外科随机对照试验的相对数量和方法学质量方面处于领先地位。